Conference Series LLC invites all the participants from all over the world to attend '7th Global Experts Meeting on Neuropharmacology' during July 31-August 02, 2017 in Milan, Italy which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Neuropharmacology 2017 is the learning of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behavior. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more. Conference Series LLC organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 1000+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Why to attend???
With members from around the world focused on learning about neuropharmacology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neuropharmacology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neuropharmacology are hallmarks of this conference.
- Neuropharmacology Students, Scientists
- Neuropharmacology Researchers
- Neuropharmacology Faculty
- Medical Colleges
- Neuropharmacology Associations and Societies
- Business Entrepreneurs
- Training Institutes
- Software developing companies
- Manufacturing Medical Devices Companies
- Data Management Companies
- Neuroimmunology and Neuroinflammation
- Neural Stem Cell
- Clinical Neuropharmacology
- Neurochemical Transmission
- Behavioral and Addiction Neuropharmacology
- Alzheimer’s Disease and Dementia
- Parkinson’s Disease
- Molecular Neuropharmacology
- Future Aspects of Neuropharmacology
- Case Study Reports
All accepted abstracts will be published in respective Conference Series LLC Journals.
See more at: http://neuro.pharmaceuticalconferences.com